TrialPharmacological research2020

Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.

Maurizio Viecca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.